Katyayani Sharma, Angelo Lanzilotto, Søren Therkelsen, Therina du Toit, F. Jørgensen, Amit Pandey
{"title":"内分泌干扰物作为前列腺癌(去势抵抗性前列腺癌)和多囊卵巢综合征治疗药物开发的“结构线索”","authors":"Katyayani Sharma, Angelo Lanzilotto, Søren Therkelsen, Therina du Toit, F. Jørgensen, Amit Pandey","doi":"10.1124/jpet.122.163500","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":344837,"journal":{"name":"ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology","volume":"33 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endocrine Disrupting Chemicals as \\\"structural cues\\\" for the development of drugs for the treatment of Prostate Cancer (Castration Resistant Prostate Cancer) and PCOS\",\"authors\":\"Katyayani Sharma, Angelo Lanzilotto, Søren Therkelsen, Therina du Toit, F. Jørgensen, Amit Pandey\",\"doi\":\"10.1124/jpet.122.163500\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":344837,\"journal\":{\"name\":\"ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology\",\"volume\":\"33 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1124/jpet.122.163500\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1124/jpet.122.163500","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Endocrine Disrupting Chemicals as "structural cues" for the development of drugs for the treatment of Prostate Cancer (Castration Resistant Prostate Cancer) and PCOS